Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

Background: Hopelessness is a risk factor for depression and suicide. There is little information on this phenomenon among patients with relapsing-remitting multiple sclerosis (RRMS), one of the most common causes of disability and loss of autonomy in young adults. The aim of this study was to assess state hopelessness and its associated factors in early-stage RRMS.

Methods: A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0-5.5 were included. The State-Trait Hopelessness Scale (STHS) was used to measure patients´ hopelessness. A battery of patient-reported and clinician-rated measurements was used to assess clinical status. A multivariate logistic regression analysis was conducted to determine the association between patients' characteristics and state hopelessness.

Results: A total of 189 patients were included. Mean age (standard deviation-SD) was 36.1 (9.4) years and 71.4% were female. Median disease duration (interquartile range-IQR) was 1.4 (0.7, 2.1) years. Symptom severity and disability were low with a median EDSS (IQR) score of 1.0 (0, 2.0). A proportion of 65.6% (n=124) of patients reported moderate-to-severe hopelessness. Hopelessness was associated with older age (p=0.035), depressive symptoms (p=<0.001), a threatening illness perception (p=0.001), and psychological and cognitive barriers to workplace performance (p=0.029) in the multivariate analysis after adjustment for confounders.

Conclusion: Hopelessness was a common phenomenon in early-stage RRMS, even in a population with low physical disability. Identifying factors associated with hopelessness may be critical for implementing preventive strategies helping patients to adapt to the new situation and cope with the disease in the long term.

Citing Articles

A new framework for understanding stress and disease: the developmental model of stress as applied to multiple sclerosis.

Fauver M, Clark E, Schwartz C Front Integr Neurosci. 2024; 18:1365672.

PMID: 38957213 PMC: 11218666. DOI: 10.3389/fnint.2024.1365672.

Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.

Sabin J, Salas E, Martin-Martinez J, Candeliere-Merlicco A, Barrero F, Alonso A Mult Scler J Exp Transl Clin. 2024; 10(2):20552173241247680.

PMID: 38638273 PMC: 11025437. DOI: 10.1177/20552173241247680.

References

Nielsen J, Saliger J, Montag C, Markett S, Nohring C, Karbe H . Facing the Unknown: Fear of Progression Could Be a Relevant Psychological Risk Factor for Depressive Mood States among Patients with Multiple Sclerosis. Psychother Psychosom. 2018; 87(3):190-192. DOI: 10.1159/000487329. View

McMillan D, Gilbody S, Beresford E, Neilly L . Can we predict suicide and non-fatal self-harm with the Beck Hopelessness Scale? A meta-analysis. Psychol Med. 2007; 37(6):769-78. DOI: 10.1017/S0033291706009664. View

Hagger M, Orbell S . The common sense model of illness self-regulation: a conceptual review and proposed extended model. Health Psychol Rev. 2021; 16(3):347-377. DOI: 10.1080/17437199.2021.1878050. View

Saposnik G, Sotoca J, Sempere A, Candeliere-Merlicco A, Diaz-Abos P, Tobler P . Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?. Mult Scler Relat Disord. 2020; 45:102354. DOI: 10.1016/j.msard.2020.102354. View

Klonsky E, Saffer B, Bryan C . Ideation-to-action theories of suicide: a conceptual and empirical update. Curr Opin Psychol. 2018; 22:38-43. DOI: 10.1016/j.copsyc.2017.07.020. View

Kurtzke J . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11):1444-52. DOI: 10.1212/wnl.33.11.1444. View

Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A . The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001; 124(Pt 5):962-73. DOI: 10.1093/brain/124.5.962. View

Feys P, Lamers I, Francis G, Benedict R, Phillips G, LaRocca N . The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. Mult Scler. 2017; 23(5):711-720. PMC: 5405844. DOI: 10.1177/1352458517690824. View

Luo J, Li L, Reangsing C, Schneider J . Effects of Psychotherapy on Hope/Hopelessness in Adults with Cancer: a Systematic Review and Meta-analysis. Int J Behav Med. 2022; 29(6):691-704. DOI: 10.1007/s12529-021-10051-9. View

10.

Honan C, Brown R, Batchelor J . Perceived cognitive difficulties and cognitive test performance as predictors of employment outcomes in people with multiple sclerosis. J Int Neuropsychol Soc. 2015; 21(2):156-68. DOI: 10.1017/S1355617715000053. View

11.

McGinley M, Goldschmidt C, Rae-Grant A . Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA. 2021; 325(8):765-779. DOI: 10.1001/jama.2020.26858. View

12.

Zaratin P, Vermersch P, Amato M, Brichetto G, Coetzee T, Cutter G . The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions. Mult Scler Relat Disord. 2022; 61:103757. DOI: 10.1016/j.msard.2022.103757. View

13.

Shen Q, Lu H, Xie D, Wang H, Zhao Q, Xu Y . Association between suicide and multiple sclerosis: An updated meta-analysis. Mult Scler Relat Disord. 2019; 34:83-90. DOI: 10.1016/j.msard.2019.06.012. View

14.

Honan C, Brown R, Hine D . The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale. Disabil Rehabil. 2013; 36(8):635-41. DOI: 10.3109/09638288.2013.805258. View

15.

Eskyte I, Manzano A, Pepper G, Pavitt S, Ford H, Bekker H . Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis. Mult Scler Relat Disord. 2018; 27:370-377. DOI: 10.1016/j.msard.2018.11.016. View

16.

McGinley M, Lapin B . The value of patient-reported outcome measures for multiple sclerosis. Mult Scler. 2022; 28(10):1489-1490. PMC: 9326853. DOI: 10.1177/13524585221111675. View

17.

Dunn S, Olamijulo G, Fuglseth H, Holden T, Swieringa L, Sit M . The State-Trait Hopelessness Scale: development and testing. West J Nurs Res. 2013; 36(4):552-70. DOI: 10.1177/0193945913507634. View

18.

Sinnakaruppan I, MacDonald K, McCafferty A, Mattison P . An exploration of the relationship between perception of control, physical disability, optimism, self-efficacy and hopelessness in multiple sclerosis. Int J Rehabil Res. 2009; 33(1):26-33. DOI: 10.1097/MRR.0b013e32832e6b16. View

19.

Alejos M, Vazquez-Bourgon J, Santurtun M, Riancho J, Santurtun A . Do patients diagnosed with a neurological disease present increased risk of suicide?. Neurologia (Engl Ed). 2022; 38(1):41-46. DOI: 10.1016/j.nrleng.2020.03.005. View

20.

Rozycka J . How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study. PLoS One. 2021; 16(10):e0258740. PMC: 8553031. DOI: 10.1371/journal.pone.0258740. View